Latest News
Collaboration Agreement Seeks to engage AI to Transform Non-clinical Pathology Assessments in Drug Discovery and Development DUBLIN, Ireland, April 23, 2024 – Deciphex, a Dublin-based digital pathology company,has entered into a Collaboration Agreement with Novartis […]
LEIDEN, The Netherlands – March 21, 2024 – Artica Therapeutics B.V. (Artica), a biotechnology company developing a pipeline of covalent small molecules for autoimmune and inflammatory disorders, today announced that industry veteran Piet Wigerinck PhD is […]
19 March 2024 – DUBLIN– We are pleased to announce that our portfolio company Fusion Pharmaceuticals Inc., (FUSN), is to be acquired for up to $2.4 billion by AstraZeneca. Fusion, is a clinical-stage biopharmaceutical company, headquartered […]
Sibylla Biotech Enters a Strategic Drug Discovery Collaboration with Ono Pharmaceutical in Central Nervous System Disorders Milan, Italy, March 14, 2024 – Sibylla Biotech announced today a drug discovery collaboration with Ono Pharmaceutical Co., Ltd. (TSE: […]
Naperville, Illinois, USA. 5 March 2024. Endotronix, Inc., a privately held company dedicated to advancing the treatment of heart failure (HF) at the intersection of digital health and medtech, presented 6-month results from its PROACTIVE-HF pivotal […]
Seroba | Business Post
https://www.pemagazine.fr/ODM2MQ/seroba-life-sciences-porte-son-fonds-iv-a-son-objectif-de-120-m
Seroba Announces Above Target Final Close of its Fund IV at €123M ($134M). • Seroba, a European life sciences venture capital firm headquartered in Dublin, with offices in Paris and Milan, announces the final close of […]
U.S.-Ireland Specialty Pharmaceutical Company’s ready-to-dilute form of a drug for the treatment of adenocarcinoma of the breast or ovary January 9, 2024 – CAMBRIDGE, Mass. – Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced today that […]
